Search results
Results from the WOW.Com Content Network
Such technology is currently being studied in more than 53 countries, including to treat sepsis in the European Union. [1] [2] Specific products include the brand names Cytosorb by Cytosorbents, Lixelle among others. [1] Their use is currently experimental; early clinical trials have generally failed to show significant improvement in survival.
An extracorporeal procedure is a medical procedure which is performed outside the body. Extracorporeal devices are the artificial organs that remain outside the body while treating a patient. Extracorporeal devices are useful in hemodialysis and cardiac surgery .
The main advantage of this system is the low extracorporeal volume ... Sepsis with multi-organ failure: ... When an apheresis system is used for therapy, the system ...
Hemoperfusion or hæmoperfusion (see spelling differences) is a method of filtering the blood extracorporeally (that is, outside the body) to remove a toxin.As with other extracorporeal methods, such as hemodialysis (HD), hemofiltration (HF), and hemodiafiltration (HDF), the blood travels from the patient into a machine, gets filtered, and then travels back into the patient, typically by ...
Appropriate antibiotic therapy is started as soon as culture results are available, or if infection is suspected (whichever is earlier). Empirical therapy may be appropriate if local microbiological surveillance is efficient. Where possible the origin of the infection is removed. When sepsis is diagnosed, appropriate local protocols are followed.
Early goal-directed therapy; Esophageal doppler; Extracorporeal carbon dioxide removal; ... Sepsis; Septic shock; Shock (circulatory) Stabilization (medicine)
Immunoadsorption was developed in the 1990s as a method of extracorporeal removal of molecules from the blood, in particular molecules of the immune system. Different number of devices/columns exist on the market, each with a different active component to which the molecule of interest attaches, allowing for selectivity in the molecules of ...
Sepsis was the most expensive condition treated in United States' hospital stays in 2013, at an aggregate cost of $23.6 billion for nearly 1.3 million hospitalizations. [132] Costs for sepsis hospital stays more than quadrupled since 1997 with an 11.5 percent annual increase. [133]